Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey
International audience EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for wom...
Published in: | European Radiology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Other Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
HAL CCSD
2017
|
Subjects: | |
Online Access: | https://hal.umontpellier.fr/hal-01806845 https://doi.org/10.1007/s00330-016-4612-z |
id |
ftinserm:oai:HAL:hal-01806845v1 |
---|---|
record_format |
openpolar |
institution |
Open Polar |
collection |
Inserm: HAL (Institut national de la santé et de la recherche médicale) |
op_collection_id |
ftinserm |
language |
English |
topic |
Breast cancer Digital breast tomosynthesis (DBT) Digital mammography Population-based screening Recall rate [SDV]Life Sciences [q-bio] |
spellingShingle |
Breast cancer Digital breast tomosynthesis (DBT) Digital mammography Population-based screening Recall rate [SDV]Life Sciences [q-bio] Sardanelli, Francesco Aase, Hildegunn Álvarez, Marina Azavedo, Edward Baarslag, Henk Balleyguier, Corinne Baltzer, Pascal Beslagic, Vanesa Bick, Ulrich Bogdanovic-Stojanovic, Dragana Briediene, Ruta Brkljacic, Boris Camps Herrero, Julia Colin, Catherine Cornford, Eleanor Danes, Jan de Geer, Gérard Esen, Gul Evans, Andrew Fuchsjaeger, Michael Gilbert, Fiona Graf, Oswald Hargaden, Gormlaith Helbich, Thomas Heywang-Köbrunner, Sylvia Ivanov, Valentin Jónsson, Ásbjörn Kuhl, Christiane Lisencu, Eugenia Luczynska, Elzbieta Mann, Ritse Marques, José Martincich, Laura Mortier, Margarete Müller-Schimpfle, Markus Ormandi, Katalin Panizza, Pietro Pediconi, Federica Pijnappel, Ruud Pinker, Katja Rissanen, Tarja Rotaru, Natalia Saguatti, Gianni Sella, Tamar Slobodníková, Jana Talk, Maret Taourel, Patrice Trimboli, Rubina Vejborg, Ilse Vourtsis, Athina Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey |
topic_facet |
Breast cancer Digital breast tomosynthesis (DBT) Digital mammography Population-based screening Recall rate [SDV]Life Sciences [q-bio] |
description |
International audience EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged. |
author2 |
University of Milan Haukeland University Hospital University of Bergen (UiB) Hospital Reina Sofia, Cordoba Karolinska University Hospital Stockholm Meander Medical Center Département d'imagerie médicale Gustave Roussy Institut Gustave Roussy (IGR) Medizinische Universität Wien = Medical University of Vienna Clinical Center University of Sarajevo Charité - UniversitätsMedizin = Charité - University Hospital Berlin Institutski put 4 Vilnius University Vilnius University Hospital Centre Zagreb and University of Zagreb School of Medicine Hospital de la Ribera Centre Hospitalier Lyon Sud CHU - HCL (CHLS) Hospices Civils de Lyon (HCL) Nottingham University Hospitals NHS Trust and University of Nottingham Computer Science Institute of Charles University Prague (IUUK) Charles University Prague (CU) ImageRive Acibadem University Ninewells Hospital and Medical School Dundee Medical University Graz University of Cambridge UK (CAM) Mater Misericordiae University Hospital (The Mater Hospital) Tokuda Hospital Sofia Value Chain, Processing and Aquaculture Matis Ohf Food Safety Environm & Genet Landspitalinn University Hospital, Reykjavik Department of Medicine III, University hospital (UKA), University of Aachen (RWTH) Rheinisch-Westfälische Technische Hochschule Aachen (RWTH)-University hospital (UKA) The Oncology Institute 'Prof. Dr. Ion Chiricuta' Radboud University Medical Center Nijmegen University of Coimbra Portugal (UC) Ghent University Hospital Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier) |
format |
Article in Journal/Newspaper |
author |
Sardanelli, Francesco Aase, Hildegunn Álvarez, Marina Azavedo, Edward Baarslag, Henk Balleyguier, Corinne Baltzer, Pascal Beslagic, Vanesa Bick, Ulrich Bogdanovic-Stojanovic, Dragana Briediene, Ruta Brkljacic, Boris Camps Herrero, Julia Colin, Catherine Cornford, Eleanor Danes, Jan de Geer, Gérard Esen, Gul Evans, Andrew Fuchsjaeger, Michael Gilbert, Fiona Graf, Oswald Hargaden, Gormlaith Helbich, Thomas Heywang-Köbrunner, Sylvia Ivanov, Valentin Jónsson, Ásbjörn Kuhl, Christiane Lisencu, Eugenia Luczynska, Elzbieta Mann, Ritse Marques, José Martincich, Laura Mortier, Margarete Müller-Schimpfle, Markus Ormandi, Katalin Panizza, Pietro Pediconi, Federica Pijnappel, Ruud Pinker, Katja Rissanen, Tarja Rotaru, Natalia Saguatti, Gianni Sella, Tamar Slobodníková, Jana Talk, Maret Taourel, Patrice Trimboli, Rubina Vejborg, Ilse Vourtsis, Athina |
author_facet |
Sardanelli, Francesco Aase, Hildegunn Álvarez, Marina Azavedo, Edward Baarslag, Henk Balleyguier, Corinne Baltzer, Pascal Beslagic, Vanesa Bick, Ulrich Bogdanovic-Stojanovic, Dragana Briediene, Ruta Brkljacic, Boris Camps Herrero, Julia Colin, Catherine Cornford, Eleanor Danes, Jan de Geer, Gérard Esen, Gul Evans, Andrew Fuchsjaeger, Michael Gilbert, Fiona Graf, Oswald Hargaden, Gormlaith Helbich, Thomas Heywang-Köbrunner, Sylvia Ivanov, Valentin Jónsson, Ásbjörn Kuhl, Christiane Lisencu, Eugenia Luczynska, Elzbieta Mann, Ritse Marques, José Martincich, Laura Mortier, Margarete Müller-Schimpfle, Markus Ormandi, Katalin Panizza, Pietro Pediconi, Federica Pijnappel, Ruud Pinker, Katja Rissanen, Tarja Rotaru, Natalia Saguatti, Gianni Sella, Tamar Slobodníková, Jana Talk, Maret Taourel, Patrice Trimboli, Rubina Vejborg, Ilse Vourtsis, Athina |
author_sort |
Sardanelli, Francesco |
title |
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey |
title_short |
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey |
title_full |
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey |
title_fullStr |
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey |
title_full_unstemmed |
Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey |
title_sort |
position paper on screening for breast cancer by the european society of breast imaging (eusobi) and 30 national breast radiology bodies from austria, belgium, bosnia and herzegovina, bulgaria, croatia, czech republic, denmark, estonia, finland, france, germany, greece, hungary, iceland, ireland, italy, israel, lithuania, moldova, the netherlands, norway, poland, portugal, romania, serbia, slovakia, spain, sweden, switzerland and turkey |
publisher |
HAL CCSD |
publishDate |
2017 |
url |
https://hal.umontpellier.fr/hal-01806845 https://doi.org/10.1007/s00330-016-4612-z |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
ISSN: 0938-7994 EISSN: 1432-1084 European Radiology https://hal.umontpellier.fr/hal-01806845 European Radiology, Springer Verlag, 2017, 27 (7), pp.2737 - 2743. ⟨10.1007/s00330-016-4612-z⟩ |
op_relation |
info:eu-repo/semantics/altIdentifier/doi/10.1007/s00330-016-4612-z info:eu-repo/semantics/altIdentifier/pmid/27807699 hal-01806845 https://hal.umontpellier.fr/hal-01806845 doi:10.1007/s00330-016-4612-z PUBMED: 27807699 PUBMEDCENTRAL: PMC5486792 |
op_doi |
https://doi.org/10.1007/s00330-016-4612-z |
container_title |
European Radiology |
container_volume |
27 |
container_issue |
7 |
container_start_page |
2737 |
op_container_end_page |
2743 |
_version_ |
1766041717203533824 |
spelling |
ftinserm:oai:HAL:hal-01806845v1 2023-05-15T16:51:36+02:00 Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey Sardanelli, Francesco Aase, Hildegunn Álvarez, Marina Azavedo, Edward Baarslag, Henk Balleyguier, Corinne Baltzer, Pascal Beslagic, Vanesa Bick, Ulrich Bogdanovic-Stojanovic, Dragana Briediene, Ruta Brkljacic, Boris Camps Herrero, Julia Colin, Catherine Cornford, Eleanor Danes, Jan de Geer, Gérard Esen, Gul Evans, Andrew Fuchsjaeger, Michael Gilbert, Fiona Graf, Oswald Hargaden, Gormlaith Helbich, Thomas Heywang-Köbrunner, Sylvia Ivanov, Valentin Jónsson, Ásbjörn Kuhl, Christiane Lisencu, Eugenia Luczynska, Elzbieta Mann, Ritse Marques, José Martincich, Laura Mortier, Margarete Müller-Schimpfle, Markus Ormandi, Katalin Panizza, Pietro Pediconi, Federica Pijnappel, Ruud Pinker, Katja Rissanen, Tarja Rotaru, Natalia Saguatti, Gianni Sella, Tamar Slobodníková, Jana Talk, Maret Taourel, Patrice Trimboli, Rubina Vejborg, Ilse Vourtsis, Athina University of Milan Haukeland University Hospital University of Bergen (UiB) Hospital Reina Sofia, Cordoba Karolinska University Hospital Stockholm Meander Medical Center Département d'imagerie médicale Gustave Roussy Institut Gustave Roussy (IGR) Medizinische Universität Wien = Medical University of Vienna Clinical Center University of Sarajevo Charité - UniversitätsMedizin = Charité - University Hospital Berlin Institutski put 4 Vilnius University Vilnius University Hospital Centre Zagreb and University of Zagreb School of Medicine Hospital de la Ribera Centre Hospitalier Lyon Sud CHU - HCL (CHLS) Hospices Civils de Lyon (HCL) Nottingham University Hospitals NHS Trust and University of Nottingham Computer Science Institute of Charles University Prague (IUUK) Charles University Prague (CU) ImageRive Acibadem University Ninewells Hospital and Medical School Dundee Medical University Graz University of Cambridge UK (CAM) Mater Misericordiae University Hospital (The Mater Hospital) Tokuda Hospital Sofia Value Chain, Processing and Aquaculture Matis Ohf Food Safety Environm & Genet Landspitalinn University Hospital, Reykjavik Department of Medicine III, University hospital (UKA), University of Aachen (RWTH) Rheinisch-Westfälische Technische Hochschule Aachen (RWTH)-University hospital (UKA) The Oncology Institute 'Prof. Dr. Ion Chiricuta' Radboud University Medical Center Nijmegen University of Coimbra Portugal (UC) Ghent University Hospital Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier) 2017-07 https://hal.umontpellier.fr/hal-01806845 https://doi.org/10.1007/s00330-016-4612-z en eng HAL CCSD Springer Verlag info:eu-repo/semantics/altIdentifier/doi/10.1007/s00330-016-4612-z info:eu-repo/semantics/altIdentifier/pmid/27807699 hal-01806845 https://hal.umontpellier.fr/hal-01806845 doi:10.1007/s00330-016-4612-z PUBMED: 27807699 PUBMEDCENTRAL: PMC5486792 ISSN: 0938-7994 EISSN: 1432-1084 European Radiology https://hal.umontpellier.fr/hal-01806845 European Radiology, Springer Verlag, 2017, 27 (7), pp.2737 - 2743. ⟨10.1007/s00330-016-4612-z⟩ Breast cancer Digital breast tomosynthesis (DBT) Digital mammography Population-based screening Recall rate [SDV]Life Sciences [q-bio] info:eu-repo/semantics/article Journal articles 2017 ftinserm https://doi.org/10.1007/s00330-016-4612-z 2022-06-24T00:12:06Z International audience EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged. Article in Journal/Newspaper Iceland Inserm: HAL (Institut national de la santé et de la recherche médicale) Norway European Radiology 27 7 2737 2743 |